PubMed Health⌕ Search

Biomedical subjects

C Kee

Publications and source records attributed to C Kee.

25 records · Page 2Linked to original sources

Serum effects on aqueous outflow during anterior chamber perfusion in monkeys.

PURPOSE: To prevent the increase in outflow facility during anterior chamber perfusion in nonhuman primates by the addition of autologous serum to Bárány's mock aqueous humor. METHODS: Total outflow facility was measured simultaneously in both eyes of living cynomolgus monkeys for 3 hours by two-level constant pressure perfusion of the anterior chambers from elevated reservoirs with Bárány's solution with (one eye) or without (opposite eye) 3%, 5%, 10%, or 15% to 20% autologous serum. In other experiments, the anterior chamber contents initially were exchanged with Bárány's solution with (one eye) or without (opposite eye) 5% autologous serum, and the facility response to intravenous pilocarpine was determined. RESULTS: Eyes perfused with serum had a lower starting facility than control eyes, with facility decreasing with increasing serum concentrations. For both groups, facility increased with perfusion time and with volume of fluid perfused through the eye, but the rate of change of facility over time and per change in volume was significantly less for the serum-treated eyes. This difference remained significant when the proportional change of facility relative to baseline level was analyzed as a function of time but not as a function of volume. Intravenous infusion of pilocarpine increased facility by approximately the same proportion relative to baseline in both groups, but the absolute change and the final facility were lower in the serum-treated eyes. CONCLUSIONS: Serum or a serum component in the vicinity of the trabecular meshwork normally may help maintain outflow resistance but may be washed away during perfusion with serum-free media.

Animals↗

Mitomycin C suppresses aqueous human flow in cynomolgus monkeys.

OBJECTIVE: To determine whether mitomycin C suppresses aqueous humor formation in cynomolgus monkeys. METHODS: Three monkeys received subconjunctival injections (50 microL) in four quadrants bilaterally, one eye receiving mitomycin C (0.5 mg/mL) and the other receiving distilled water. Seven monkeys underwent 360 degrees conjunctival peritomy bilaterally and episcleral application of mitomycin C-soaked (0.5 mg/mL) cellulose sponges for 5 minutes in all four quadrants unilaterally. Aqueous humor flow was measured fluorophotometrically 1 and 3 days, and 1, 2, and 4 weeks after subconjunctival injection; and 3 days and 1, 2, 3, and 4 weeks after episcleral application. RESULTS: There was no change in aqueous flow in either eye and no difference between eyes following subconjunctival injection. Aqueous flow was reduced by 8% +/- 7% (mean +/- SEM), 20% +/- 3% (P < .01), 9% +/- 10%, and 0% +/- 4% compared with contralateral controls 1, 2, 3, and 4 weeks, respectively, after episcleral application of mitomycin C. CONCLUSIONS: Episcleral application of mitomycin C can produce at least a modest short-term reduction of aqueous humor flow in primates. Reduced aqueous flow might contribute to early postoperative hypotony following trabeculectomy with mitomycin C.

Animals↗

Experimentally designed glaucoma implant surgery with mitomycin C in rabbit.

An attempt was made to observe the possibility of controlling intraocular pressure (IOP) without hypotony and ocular motility disorder by installing an experimentally designed glaucoma implant through a small conjunctival incision with the aid of a stylet and maintaining the aqueous reservoir using mitomycin C (MMC). The implant was made of silicone tube, of which one end was occluded by glue and on the same end 4 check-valve-like slits were made. Thirty-five healthy white rabbits were used and subdivided into 4 groups. In groups I to III, implants having 2.0, 2.5, 3.0 mm slit lengths, respectively, were installed with MMC application in one eye of each of the 10 rabbits. In group IV, a 2 mm slit-length implant was installed without MMC in one eye of each of the 5 rabbits. Pneumatonometry and ultrasonography were performed to check the IOP and the formation of aqueous reservoir in the implanted eyes for 8 weeks. In group I through III, there was a statistically significant 4-5 mmHg pressure-lowering effect in the implanted eyes compared to the contralateral control eyes for 8 weeks. The aqueous reservoirs were observed throughout the follow-up period. In group IV, we could observe neither a pressure-lowering effect nor aqueous reservoir formation in the implanted eyes after 2 weeks postoperatively. Hypotony did not occur in implanted eyes in any of the groups. This study shows the possibility of IOP control by installing a specially designed glaucoma implant with application of MMC.

Animals↗

Profound long-term hypotony without maculopathy after trabeculectomy with antimetabolite.

A 71-year-old white woman with primary open angle glaucoma received trabeculectomy with antimetabolite. After laser suture lysis, intraocular pressure has remained at 1-2 mmHg for 23 months and 12 months in the right and left eye, respectively. However, visual acuity has remained at the preoperative levels of 6/6 and 6/7.5 in the right and left eye, respectively, without hypotony maculopathy in either eye.

Aged↗

Effect of 8-Br cGMP on aqueous humor dynamics in monkeys.

PURPOSE: To evaluate the effect of 8-bromo cGMP (Br cGMP) on aqueous humor flow rate and outflow facility in monkey eyes. METHODS. Aqueous humor flow rate was measured fluorophotometrically after topical, intracameral, or intravitreal administration of Br cGMP in one eye and normal saline in the other eye. Outflow facility was determined by two-level constant pressure perfusion after intracameral bolus injection of Br cGMP in one eye and Bárány's solution in the other eye. RESULTS: Aqueous humor flow rate decreased by 15% to 20% after intravitreal administration of 10 or 30 micrograms of Br cGMP. There was no flow response to smaller or larger intravitreal doses nor to drugs administered via other routes. Outflow facility increased by 25% to 30% after intracameral infusion of 100 or 300 < gm > g Br cGMP, but not after smaller doses. CONCLUSIONS: cGMP may be involved in the regulation of aqueous humor formation and outflow facility and their responses to pharmacologic agents.

Administration, Topical↗